Microangiopathy in Patients with Chronic Myelogenous Leukemia Treated with Interferon

By Creutzig A.   Freund M.   Caspary L.   Alexander K.  

Microvascular Research, Vol. 52, Iss. 3, 1996-11 ,pp. : 288-292

Academic Press

Access to resources Recommend Favorite

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

By Nakagawa Mina   Sakamoto Naoya   Ueyama Mayumi   Mogushi Kaoru   Nagaie Satoshi   Itsui Yasuhiro   Azuma Seishin   Kakinuma Sei   Tanaka Hiroshi   Enomoto Nobuyuki   Watanabe Mamoru  

Journal of Gastroenterology, Vol. 45, Iss. 6, 2010-06 ,pp. : 656-665

Springer Publishing Company

Access to resources Recommend Favorite

Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis B

By Husa P.   Klusakova J.   Janckova J.   Husova L.   Horalek F.  

European Journal of Internal Medicine, Vol. 13, Iss. 2, 2002-03 ,pp. : 129-131

Elsevier

Access to resources Recommend Favorite

Effect of single-dose administration of recombinant interferon-alpha2b on gastric myoelectrical activity in patients with chronic hepatitis C

By Jonderko Krzysztof   Krusiec-Świdergoł Beata   Mazur Włodzimierz   Kasicka-Jonderko Anna   Gonciarz Maciej   Błońska-Fajfrowska Barbara   Gonciarz Zbigniew  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1035-1044

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase Levels

By  

Digestion, Vol. 65, Iss. 2, 2002-05 ,pp. : 127-130

Karger

Access to resources Recommend Favorite